Pangyo, Gyeonggi, 22 Jan, 2016| On 27 Jan, Institut Pasteur Korea (IPK, CEO: Dr. Hakim Djaballah) and the Gyeonggi Provincial Government invites all Gyeonggi province-based pharmaceutical companies, bio-companies, and research institutions to a briefing session to discuss a new research support project.
 
The venture, supported by the Gyeonggi Provincial Government, will reinforce research capabilities of Gyeonggi province-based institutions.  Collaborators will leverage IPK’s excellent screening platform and scientific personnel to discover first-in-class compounds.  A total of 5 projects will be selected for 2016.
 
Time: 14:00 ~ 16:00 PM, 27 Jan, 2016
Venue: 1st floor Conference Room1 at Institut Pasteur Korea
(16 Daewangpangyo-ro 712 beon-gil, Bundang-gu, Seongnam-si, Gyeonggi)
Contact: Comm team Soyun Kim (031-8018-8043 | publicrelations@ip-korea.org)
 
#       #       #       #       #       #
 
About Institut Pasteur Korea
Institut Pasteur Korea, located in Pangyo, was founded in 2004. It is a private institution devoted to discovery biology for infectious diseases. IPK’s unique translational capabilities and small molecule intervention technology make it possible to rapidly address unmet global health needs through diagnostics for detection and prevention. IPK strives to have fostering collaborations, partnerships, and educational outreach to share its knowledge and research know-how. Institut Pasteur Korea is a member of the Institut Pasteur International Network which brings together 33 institutes located in 29 countries, united by the same mission, culture, and values. Leveraging vast human and scientific community, the Network is involved in international research projects, public health, teaching and training programs. By its diversity and global presence, the Institut Pasteur International Network aims to respond, in an innovative way, to international public health issues and priorities.